MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Alpha-synuclein"

  • MDS Virtual Congress 2021

    Oligodendroglial-derived exosomes as mediators of α-synuclein pathology in MSA-like models

    M. Vetsi, G. Tsaka, P. Mavroeidi, F. Arvanitaki, M. Zweckstetter, S. Becker, PH. Jensen, L. Stefanis, M. Xilouri (Athens, Greece)

    Objective: The current study focuses in elucidating the contribution of oligodendroglial-derived exosomes in the development and spread of α-Synuclein (αSyn) pathology in Multiple System Atrophy…
  • MDS Virtual Congress 2021

    Neurofilament light chain serum levels in E46K-SNCA mutation carriers

    A. Murueta-Goyena, MA. Acera, N. Ayo, M. Carmona-Abellán, R. Del Pino, I. Gabilondo, B. Tijero, T. Fernandez, M. Ruiz, JC. Gómez-Esteban, E. Capetillo, R. Cipriani, F. Zallo, F. Cavaliere (Barakaldo, Spain)

    Objective: To demonstrate the usefulness of measuring the concentration of neurofilament light chain (NfL) in blood using Single Molecule Array matrix (SiMoA, Quanterix) as a…
  • MDS Virtual Congress 2020

    A novel likely pathogenic SNCA variant associated with Parkinson’s disease

    B. Minafra, G. Buongarzone, S. Gana, M.L Valente, I. Palmieri, T. Biagini, M. Plumari, M. Avenali, R. Zangaglia, T. Mazza, C. Cereda, C. Pacchetti, E.M Valente (Pavia, Italy)

    Objective: To report a novel SNCA likely pathogenic variant. Background: The A53T mutation in the SNCA gene, encoding alpha-synuclein (a-syn), was the first established genetic…
  • MDS Virtual Congress 2020

    Alpha-synuclein preformed fibril (PFF)-triggered synucleinopathy recapitulates neurochemical features of human PD: A PET study in rats

    C. Sortwell, J. Patterson, C. Kemp, K. Miller, A. Stoll, M. Duffy, K. Luk, V. Sossi (Grand Rapids, MI, USA)

    Objective: To investigate longitudinal dopaminergic deficits and similarity to human Parkinson’s disease (PD) using PET imaging in the rat alpha-synuclein (a-syn) preformed fibril (PFF) model.…
  • MDS Virtual Congress 2020

    Quantifying movement to measure Parkinson’s Disease severity and progression in a Phase 2 Study (SPARK)

    K.P Kilambi, S. Khan, J. Osik, T. Herrero, J. Edgerton, K. Erb, K. Hallock, M. Brys, M. Yang, J. Xiao, I. Sapir, T. Fox, P. Bergethon (Cambridge, MA, USA)

    Objective: To develop and evaluate objective measures of Parkinson’s disease (PD) severity and progression by applying dynamical systems analysis to inertial sensor kinematic data. Background:…
  • MDS Virtual Congress 2020

    Variants in the saposin D domain of prosaposin gene are linked to Parkinson’s disease

    Y. Oji, T. Hatano, S. Ueno, M. Funayama, K. Ishikawa, A. Okuzumi, S. Noda, S. Sato, W. Satake, T. Toda, Y. Li, T. Hino-Takai, S. Kakuta, T. Tsunemi, H. Yoshino, K. Nishioka, T. Hattori, Y. Mizutani, T. Mutoh, F. Yokochi, Y. Ichinose, K. Koh, K. Shindo, Y. Takiyama, T. Hamaguchi, M. Yamada, M. Farrer, Y. Uchiyama, W. Akamatsu, J. Matsuda, Y. Wu, N. Hattori (Tokyo, Japan)

    Objective: To investigate whether the variants of prosaposin can be linked to Parkinson's disease (PD) [1]. Background: Recent growing investigations have promoted the evidence of…
  • MDS Virtual Congress 2020

    Predicting Longitudinal Atrophy in Parkinson’s Disease using SIR model

    A. Abdelgawad, S. Rahayel, C. Tremblay, A. Vo, Y.Q Zheng, R. Markello, B. Misic, A. Dagher (Montreal, QC, Canada)

    Objective: To predict longitudinal brain changes in Parkinson's disease (PD) using an agent-based model. Background: Considerable evidence suggests that α-synuclein(α-syn) behaves in a prion-like fashion,…
  • MDS Virtual Congress 2020

    Morphological changes of retina in patients with Parkinson’s disease and the role of α-synuclein in retinal damage

    L. Man, Z. Wei (Chengdu, China)

    Objective: To analyze the characteristics of retinal structural changes in patients with PD by the noninvasive technology of OCT. Demonstrate the role of α-syn in pathological changes of…
  • MDS Virtual Congress 2020

    DJ1 and α-Synuclein as CSF biomarkers and gene polymorphisms: association with clinical parameters in Parkinson’s disease

    T. Syed, T. SD, R. Kandadai, V. Kutala, R. Borgohain (Hyderabad, India)

    Objective: To analyze the CSF α-Synuclein and DJ1 Biomarkers correlating with SNCA and DJ1 gene polymorphisms and clinical parameters in PD. Background: Currently there is…
  • MDS Virtual Congress 2020

    Genetic Profiling of Early Synucleinopathy in Rat Nigrostriatal Dopamine Neurons

    J. Patterson, C. Kemp, M. Duffy, J. Howe, C. Russell, A. Stoll, K. Miller, J. Beck, S. Counts, K. Steece-Collier, K. Luk, C. Sortwell (Grand Rapids, MI, USA)

    Objective: Identification of changes in gene expression in rat nigral neurons associated with early phases of synucleinopathy. Background: Early phases of synucleinopathies such as Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 60
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley